What is the purpose of this trial?
The objective of the study is to determine the efficacy of intravenous infliximab administered at the time of transplantation, prior to reperfusion, on 2-year kidney transplant survival and function.
Ages: 18 years and older
Icahn School of Medicine at Mount Sinai
Dates: 10/19/2015 - 08/01/2020
Last Updated: 10/27/2015
Study HIC#: 1507016169